台華新材(603055.SH):馮建英通過增資持有福華環球70%股份
格隆匯5月27日丨台華新材(603055.SH)公佈,公司於近日收到公司控股股東福華環球關於其權益變動的告知函,調整完成後,施秀幼(公司實際控制人之一)持有福華環球30%股份,馮建英(公司實際控制人之一施清島之配偶)通過增資持有福華環球70%股份。施清島、施秀幼、馮建英三方簽署了《一致行動人協議書》,另外,馮建英簽署了《不可撤銷的授權委託書》,將其在福華環球的股東表決權不可撤銷地授予施清島行使。
本次控股股東內部權益變動後,公司的控股股東和實際控制人均未發生變化,公司控股股東仍為福華環球,實際控制人仍為施秀幼、施清島姐弟。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.